Skip to main content

Table 2 Treatment and outcome of children with KD

From: Neutropenia after intravenous immunoglobulin therapy is associated with coronary artery lesions in children with Kawasaki disease: a case control study

Group NKD NNKD P value
IVIG treatment duration (days) 7(6–8) 6(6–7) 0.002
IVIG dosage    0.009
2d/kg*1d 77(14.3%) 462(85.7%)  
1 g/kg*2d 43(22.4%) 149(77.6%)  
dipyridamole 39(37.5%) 224(33.3%) 0.404
CAL after treatmenta 58(31.9%) 250(22.8%) 0.008
CAA after treatment 4(6.9%) 26(10.4%) 0.418
IVIG nonresponders 5(3.0%) 51(5.8%) 0.167
Gender    0.715
 Female 63(32.0%) 389(33.3%)  
 Male 134(68.0%) 779(66.7%)  
  1. aCAL after treatment is defined as patients with persistent CAL after IVIG treatment. Values are expressed as Median (interquartile range) / Number (percentage). Continuous variables were compared using Kruskal-Wallis test, categorical variables were compared using Chi-square test